The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients
Abstract
Introduction: Implantable cardioverter defibrillators (ICDs) are increasingly being used in high‐risk long QT syndrome (LQTS) patients, but there are limited data regarding clinical experience with this therapeutic modality. The aim of this study is to describe the clinical characteristics of 125 LQTS patients treated with ICDs compared with LQTS patients having similar risk indications who were not treated with ICDs. Methods and Results: Among 125 LQTS patients with ICDs, there were 54 cardiac arrest survivors, 19 patients who had ICDs implanted due to recurrent syncope despite beta‐blocker therapy, and 52 patients with ICDs implanted due to other reasons, including syncope and LQTS‐related sudden death in a close family member. Patients with cardiac arrest and those with recurrent syncope despite beta‐blocker therapy (n = 73) were compared to 161 LQTS patients who had similar indications (89 cardiac arrest and 72 recurrent syncope despite beta‐blocker therapy) but did not receive ICDs. Total mortality was the endpoint of the analysis. There was 1 (1.3%) death in 73 ICD patients followed an average of 3 years, whereas there were 26 deaths (16%) in non‐ICD patients during mean 8‐year follow‐up (P = 0.07 from log rank test from Kaplan‐Meier curves). Conclusion: ICDs provide an important therapeutic option to prevent sudden arrhythmic death in high‐risk LQTS patients. A long‐term prospective study is needed to determine the benefit of this therapeutic modality in LQTS patients. (J Cardiovasc Electrophysiol, Vol. 14, pp. 337‐341, April 2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for the long QT syndrome. An update.
Schwartz, P. J., Moss, A. J., Vincent, G. M., & Crampton, R. S. (1993) · Circulation · doi:10.1161/01.cir.88.2.782 · Cited by 1,181
Self-citationThe long QT syndrome. Prospective longitudinal study of 328 families.
Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 968
Self-citationEffectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
Moss, A. J., Zareba, W., Hall, W. J., Schwartz, P. J., Crampton, R. S., Benhorin, J., Vincent, G. M., Locati, E. H., Priori, S. G., Napolitano, C., et al. (2000) · Circulation · doi:10.1161/01.cir.101.6.616 · Cited by 841
Self-citationMaron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citationInfluence of the Genotype on the Clinical Course of the Long-QT Syndrome
Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 754
Self-citationThe Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT Syndrome
Vincent, G. M., Timothy, K. W., Leppert, M., & Keating, M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209173271204 · Cited by 622
Locati, E. H., Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Lehmann, M. H., Towbin, J. A., Priori, S. G., Napolitano, C., Robinson, J. L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2237 · Cited by 493
Self-citationMoss, A. J., Zareba, W., Kaufman, E. S., Gartman, E., Peterson, D. R., Benhorin, J., Towbin, J. A., Keating, M. T., Priori, S. G., Schwartz, P. J., et al. (2002) · Circulation · doi:10.1161/hc0702.105124 · Cited by 397
Self-citationSilka, M. J., Kron, J., Dunnigan, A., & Dick, M. (1993) · Circulation · doi:10.1161/01.cir.87.3.800 · Cited by 280
Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome.
Moss, A. J., Liu, J. E., Gottlieb, S., Locati, E. H., Schwartz, P. J., & Robinson, J. L. (1991) · Circulation · doi:10.1161/01.cir.84.4.1524 · Cited by 194
Self-citationThe Idiopathic Long QT Syndrome: Pathogenetic Mechanisms and Therapy
Schwartz, P. J., & Locati, E. H. (1985) · European Heart Journal · doi:10.1093/eurheartj/6.suppl_d.103 · Cited by 148
Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With β-Blockers and Continuous Pacing
Dorostkar, P. C., Eldar, M., Belhassen, B., & Scheinman, M. M. (1999) · Circulation · doi:10.1161/01.cir.100.24.2431 · Cited by 144
Risk of cardiac events in family members of patients with long QT syndrome
Zareba, W., Moss, A. J., le Cessie, S., Locati, E. H., Robinson, J. L., Hall, W. J., & Andrews, M. L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)60383-2 · Cited by 142
Self-citationUse of Implantable Cardioverter-Defibrillators in the Congenital Long QT Syndrome
Groh, W. J., Silka, M. J., Oliver, R. P., Halperin, B. D., McAnulty, J. H., & Kron, J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00403-3 · Cited by 125
Brugada, J., Brugada, R., & Brugada, P. (2000) · Journal of Electrocardiology · doi:10.1054/jelc.2000.20322 · Cited by 112
Tavernier, R., Gevaert, S., Sutter, J. D., Clercq, A. D., Rottiers, H., Jordaens, L. J. L. M., & Fonteyne, W. (2001) · Heart · doi:10.1136/heart.85.1.53 · Cited by 85
Breithardt, G., Wichter, T., Haverkamp, W., Borggrefe, M., Block, M. S., Hammel, D., & Scheld, H. H. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90103-1 · Cited by 79
Implantable Cardioverter-Defibrillators in Children: A Single-Institutional Experience
Wilson, W. R., Greer, G. E., & Grubb, B. P. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)01434-3 · Cited by 58
Zaręba, W., & Moss, A. J. (2001) · Journal of Electrocardiology · doi:10.1054/jelc.2001.28863 · Cited by 27
Self-citation
Cited by
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Heart Disease and Stroke Statistics—2014 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,215
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Metadata
- Authors
- ZAREBA, W., MOSS, A. J., DAUBERT, J. P., HALL, W. J., ROBINSON, J. L., & ANDREWS, M.
- Venue
- Journal of Cardiovascular Electrophysiology
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 14
- Issue
- 4
- Pages
- 337-341
- ISSN
- 1045-3873 (ISSN-L)
- 1540-8167
- OpenAlex
- W2159701763
- Cited by
- 314
- References
- 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.